Overview
Study design:
A prospective phase II, non-randomized observational study of dose-escalated pencil beam proton therapy re-irradiation for pelvic recurrences from rectal cancer.
Re-irradiation is either a part of neo-adjuvant treatment or as a definitive treatment strategy for un-resectable recurrences.
Eligibility
Inclusion Criteria:
- • Locally recurrent rectal cancer.
- Bioptically verified (adenocarcinoma )
- Available dose plan from primary radiotherapy
- Previous pelvic RT (>30Gy EQD2)
- Evaluated in MDT-conferences (Herlev, Aarhus)
- Age>18 years
- PS 0-2
- Adequate organ function
- Informed consent
Exclusion Criteria:
- Non-resectable distant metastases (PET-CT)
- Unable to undergo MRI, PET-CT
- Inability to attend full course radiotherapy and follow up in the out patient clinic.